MP07-66
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
An inhibitor of the SET-PP2A protein-protein interaction, increases PP2A activity in isolated... more
Product information "MP07-66"
An inhibitor of the SET-PP2A protein-protein interaction, increases PP2A activity in isolated human B-CLL cells at 3 and 8 µM, does not decrease plasma membrane S1P1 levels in isolated human B-CLL cells at 8 µM, induces apoptosis in isolated human B-CLL cells when used alone or in combination with dasatinib. Formulation: A solution in ethanol. InChI: InChI=1S/C19H33NO3/c1-4-7-8-9-14-23-18-12-10-17(11-13-18)15-20-16-19(21-5-2)22-6-3/h10-13,19-20H,4-9,14-16H2,1-3H3. InChIKey: WBCMPXCRPPCZSO-UHFFFAOYSA-N. SMILES: CCCCCCOC(C=C1)=CC=C1CNCC(OCC)OCC
| Keywords: | N-(2,2-diethoxyethyl)-4-(hexyloxy)-benzenemethanamine |
| Supplier: | Cayman Chemical |
| Supplier-Nr: | 42337 |
Properties
| Application: | SET (I2PP2A)-PP2A protein-protein interaction inhibitor |
| MW: | 323.47 D |
| Formula: | C19H33NO3 |
| Purity: | >98% |
| Format: | Solution |
Database Information
| CAS : | 1938056-90-6| Matching products |
| KEGG ID : | K11290 | Matching products |
Handling & Safety
| Storage: | -20°C |
| Shipping: | -20°C (International: -20°C) |
| Signal Word: | Danger |
| GHS Hazard Pictograms: |
|
| H Phrases: | H225, H316, H319, H333 |
| P Phrases: | P210, P233, P240, P241, P242, P243, P264, P280, P303+361+353, P304+312, P305+351+338, P332+313, P337+313, P370+378, P403+235, P501 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed